Barclays
RENE

Barclays’s Cartesian Growth Corp II RENE Stock Holding History

Barclays’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,761
Closed -$236K – 5325
2023
Q3 		$236K Hold
21,761
– – ﹤0.01% 3215
2023
Q2 		$232K Buy
+21,761
New +$230K ﹤0.01% 3174

Other funds holding RENE

FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Barclays's RENE Position: Q4 2023 in Review

Barclays sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 21,761 shares — an estimated $236K sold.

Barclays first reported a position in RENE in Q2 2023 and held it in 2 quarters. The position peaked at $236K in Q3 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • Barclays reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • Barclays sold 21,761 Cartesian Growth Corp II shares in Q4 2023, an estimated $236K.
  • Barclays first reported a position in Cartesian Growth Corp II in Q2 2023 and held it in 2 quarters.
  • Barclays's Cartesian Growth Corp II position peaked at $236K in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.